Paloma Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Paloma Partners's BIIB Position: Q4 2024 in Review
Paloma Partners sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,824 shares — an estimated $354K sold.
Paloma Partners first reported a position in BIIB in Q2 2013 and held it in 36 quarters. The position peaked at $85.7M in Q4 2016. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Paloma Partners reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 1,824 Biogen shares in Q4 2024, an estimated $354K.
- Paloma Partners first reported a position in Biogen in Q2 2013 and held it in 36 quarters.
- Paloma Partners's Biogen position peaked at $85.7M in Q4 2016.
- 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.